Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS‐CoV‐2 (COVID‐19) pandemic …

G Paolino, SR Mercuri, P Bearzi… - Dermatologic …, 2020 - Wiley Online Library
The precision medicine era has helped to better manage patients with immunological and
oncological diseases, improving the quality of life of this class of patients. Regarding the …
被引用次数：4 相关文章

Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS‐CoV‐2 (COVID‐19) pandemic …

G Paolino, SR Mercuri, P Bearzi… - Dermatologic …, 2020 - search.ebscohost.com
The precision medicine era has helped to better manage patients with immunological and
oncological diseases, improving the quality of life of this class of patients. Regarding the …
[HTML] nih.gov

[HTML][HTML] Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS‐CoV‐2 (COVID‐19) …

G Paolino, SR Mercuri, P Bearzi… - Dermatologic …, 2020 - ncbi.nlm.nih.gov
The precision medicine era has helped to better manage patients with immunological and
oncological diseases, improving the quality of life of this class of patients. Regarding the …

Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS-CoV-2 (COVID-19) pandemic …

G Paolino, SR Mercuri, P Bearzi, C Mattozzi - Dermatologic Therapy, 2020 - europepmc.org
The precision medicine era has helped to better manage patients with immunological and
oncological diseases, improving the quality of life of this class of patients. Regarding the …

Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS-CoV-2 (COVID-19) pandemic …

G Paolino, SR Mercuri, P Bearzi… - Dermatologic …, 2020 - pubmed.ncbi.nlm.nih.gov
The precision medicine era has helped to better manage patients with immunological and
oncological diseases, improving the quality of life of this class of patients. Regarding the …

Systemic Immunobiological, Immunosuppressant and Oncologic Agents for the Treatment of Dermatologic Diseases during the SARS-Cov-2 (COVID19) Pandemic …

G Paolino, SR Mercuri, P Bearzi… - DERMATOLOGIC …, 2020 - iris.uniroma1.it
The Precision Medicine Era has helped to better manage patients with immunological and
oncological disease, improving the quality of life of this class of patients. Regarding the …

Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS-CoV-2 (COVID-19) pandemic …

G Paolino, SR Mercuri, P Bearzi, C Mattozzi - DERMATOLOGIC …, 2020 - iris.unisr.it
The precision medicine era has helped to better manage patients with immunological and
oncological diseases, improving the quality of life of this class of patients. Regarding the …

Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS-CoV-2 (COVID-19) pandemic …

G Paolino, SR Mercuri, P Bearzi, C Mattozzi - 2020 - cabidigitallibrary.org
The precision medicine era has helped to better manage patients with immunological and
oncological diseases, improving the quality of life of this class of patients. Regarding the …